国家二级教授 主任医师 博士生导师

华中科技大学同济医学院附属协和医院心脏大血管外科主任

器官移植中心主任，心研所所长

中国医师协会心血管外科分会会长

中华医学会胸心血管外科分会副主任委员

国家心血管疾病医疗质量控制中心专家委员会副主任委员

国家心脏移植技术医疗质量控制中心专家委员会副主任委员

亚洲胸心外科学会（ASCVTS）常务理事，美国胸心血管外科学会（AATS）、国际微创胸心外科学会（ISMICS）会员

主持国家级重大／重点项目12项，发表论文400余篇，申请/授权国家发明专利36项，主编/主审专著9部

以第一完成人获国家科技进步二等奖1项，省部科技进步特等奖1项/一等奖5项

一级主任医师，博士生导师，国家卫健委突出贡献中青年专家

中南大学湘雅二医院心血管外科教研室主任，小儿心血管外科主任
心血管用生物工程材料湖南省工程实验室主任
中国心血管外科医师协会先心病外科专业委员会委员，国家心血管外科先心病外科专家委员会委员，湖南省预防医学会先天性心脏病防治专业委员会主任委员
肺动脉替代材料牛颈静脉带瓣管道研究获第十届湖南省医学科技一等奖；2014年度湖南省自然科学奖一等奖，均排名第一
主要研究方向：复杂先心病的外科治疗；胎儿先心病产前产后诊疗一体化研究；心血管用生物替代材料研发
诊疗特色：国际上首先采用心内管道技术治疗高难度无关型右室双出口；国内率先开展右心保护技术法洛四联症根治术；省内率先开展高难度Nikaidoh手术、ROSS手术、Konno手术、双调转手术、小婴儿瓣膜替换手术及Slide气管成型手术等复杂先心病术式；成功实施国内最小儿童心肺联合移植及省内最小年龄心脏移植。

Zhong Shi, Wu, First-level chief physician, doctoral supervisor, young and middle-aged experts with outstanding contributions to the National Health Commission , Professor, Department of Cardiovascular Surgery, Second Xiangya Hospital, Central South University, 

Deputy Director of Cardiovascular Surgery, director of Congenital heart disease, Director of Hunan Engineering Laboratory of Cardiovascular Biomaterials. The chairman of Hunan Congenital heart Disease Prevention and Treatment Committee. Member of Pediatric Cardiovascular Surgery Committee of Chinese Medical Association, member of National Cardiovascular Expert Committee; Member of Chinese Society of Cardiovascular Surgeons. Led the congenital heart disease surgical team to achieve an annual increase of more than 10% for consecutive years, and the mortality rate was controlled at about 1% of the domestic advanced level; Individuals have performed nearly 10,000 congenital heart surgery. He led and organized the integrated management of prenatal and postnatal diagnosis and treatment of fetal congenital heart disease in Hunan Province. It is the first country to carry out the research and application of pulmonary valve conduit in China. The international first "intracardiac conduit connection" technique is used to treat double outlet right ventricle with unrelated ventricular septal defect, which greatly reduces the difficulty of operation and operative mortality. China took the lead in the minimally invasive small incision repair of congenital heart disease and repair of tetralogy of Fallot with right heart protection technology, and successfully carried out the heart-lung transplantation of the youngest child in China and the heart transplantation of children in the province. In Hunan Province, a number of difficult and complex surgical procedures such as Ross operation, Ross-Konno operation, ccTGA double switch operation, Nikaidoh operation, total aortic arch replacement in children, reconstruction of unilateral absence of pulmonary artery, tricuspid valve Cone plasty, systemic pulmonary collateral branch fusion operation, and correction of incardiac anomalous pulmonary venous connection have been carried out.